Chemoinformaics analysis of 3-phosphoglyceric acid
| Molecular Weight | 186.056 | nRot | 4 |
| Heavy Atom Molecular Weight | 179 | nRig | 3 |
| Exact Molecular Weight | 185.993 | nRing | 0 |
| Solubility: LogS | -0.041 | nHRing | 0 |
| Solubility: LogP | -2.176 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 18.9216 |
| nHD | 4 | BPOL | 18.3344 |
| QED | 0.347 |
| Synth | 4.975 |
| Natural Product Likeliness | 0.158 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.088 |
| HIA | 0.135 |
| CACO-2 | -5.791 |
| MDCK | 0.00663441 |
| BBB | 0.707 |
| PPB | 0.111476 |
| VDSS | 0.349 |
| FU | 0.905226 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.063 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.18 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.008 |
| CL | 1.403 |
| T12 | 0.925 |
| hERG | 0.008 |
| Ames | 0.172 |
| ROA | 0.011 |
| SkinSen | 0.798 |
| Carcinogencity | 0.185 |
| EI | 0.991 |
| Respiratory | 0.677 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.901003 |